NCT05250882

Brief Summary

This multicenter open-label trial is designed to evaluate if the implementation of an enhanced peri-operative care protocol results in an optimal intraoperative condition of the patient and in a decrease in incidence of anastomotic leakage after colorectal resection as compared to current practice.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
2 countries

9 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 22, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

February 22, 2022

Status Verified

February 1, 2022

Enrollment Period

2 years

First QC Date

January 20, 2022

Last Update Submit

February 21, 2022

Conditions

Keywords

RiskfactorColorectal resectionIntraoperative conditionPerioperative care

Outcome Measures

Primary Outcomes (1)

  • Number of modifiable intraoperative CAL risk factors present during surgery as assessed by the DoubleCheck list

    The primary outcome of the study is the intraoperative condition of the patient measured by the number of modifiable intraoperative CAL risk factors present in the patient. During the operation, the Double Check list will be completed. The list exists of 6 risk factors of interest: * Anemia: haemoglobin level \< 7,5 (women) or \< 8.0 (men) mmol/L * Hypothermia: temperature \<36 degrees Celcius * Hyperglycemia: glucose level \>10 mmol/L * Ue of vasopressor drugs: yes * Epidural analgesia * Incorrect antibiotic prophylaxis: not administered within 15-60 minutes prior to incision The number of risk factors present will be counted and a score of 0 to 6 will be given to each individual patient.

    Intraoperative phase

Secondary Outcomes (5)

  • Colorectal anastomotic leakage (CAL)

    30 days after surgery

  • Postoperative complications

    30 days after surgery

  • Postoperative mortality

    30 days after surgery

  • Hospital Stay

    30 days after surgery

  • Readmission

    30 days after surgery

Study Arms (2)

Double Check enhanced perioperative care protocol

EXPERIMENTAL

Perioperative care according to a best practice protocol focussing on optimizing the intraoperative condition of the patient and thereby minimalize exposure to 6 known modifiable independent intraoperative risk factors: anemia, hypothermia, epidural anesthesia, vasopressor drug administration, incorrect antibiotic prophylaxis and hyperglycemia.

Other: Enhanced perioperative care protocol

Current practice

NO INTERVENTION

Perioperative care according to usual practice. Historical controls from the previously conducted LekCheck study will be used as replacement of a control arm.

Interventions

See arm/group description

Double Check enhanced perioperative care protocol

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and above
  • Bowel (small intestine/colon/rectal) resection with creation of a primary anastomosis
  • Ability to give informed consent

You may not qualify if:

  • The need for emergency surgery
  • Scheduled operation concerning a reoperation for complications from recent surgery (within 3 months after the initial procedure).
  • The inability to read or understand informed consent material

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

UZA

Antwerp, Belgium

Location

Elkerliek

Helmond, Limburg, Netherlands

Location

Maastricht UMC+

Maastricht, Limburg, Netherlands

Location

Jeroen Bosch Ziekenhuis

's-Hertogenbosch, North Brabant, Netherlands

Location

Bernhoven

Uden, North Brabant, Netherlands

Location

Maxima Medisch Centrum

Veldhoven, North Brabant, Netherlands

Location

Amsterdam UMC

Amsterdam, North Holland, Netherlands

Location

Dijklander Ziekenhuis

Hoorn, North Holland, Netherlands

Location

ZorgSaam

Terneuzen, Zeeland, Netherlands

Location

Related Publications (3)

  • Huisman DE, Reudink M, van Rooijen SJ, Bootsma BT, van de Brug T, Stens J, Bleeker W, Stassen LPS, Jongen A, Feo CV, Targa S, Komen N, Kroon HM, Sammour T, Lagae EAGL, Talsma AK, Wegdam JA, de Vries Reilingh TS, van Wely B, van Hoogstraten MJ, Sonneveld DJA, Veltkamp SC, Verdaasdonk EGG, Roumen RMH, Slooter GD, Daams F. LekCheck: A Prospective Study to Identify Perioperative Modifiable Risk Factors for Anastomotic Leakage in Colorectal Surgery. Ann Surg. 2022 Jan 1;275(1):e189-e197. doi: 10.1097/SLA.0000000000003853.

    PMID: 32511133BACKGROUND
  • van Rooijen SJ, Huisman D, Stuijvenberg M, Stens J, Roumen RMH, Daams F, Slooter GD. Intraoperative modifiable risk factors of colorectal anastomotic leakage: Why surgeons and anesthesiologists should act together. Int J Surg. 2016 Dec;36(Pt A):183-200. doi: 10.1016/j.ijsu.2016.09.098. Epub 2016 Oct 15.

    PMID: 27756644BACKGROUND
  • de Wit A, Bootsma BT, Huisman DE, Kazemier G, Daams F; Taskforce Anastomotic Leakage. Early detection and correction of preoperative anemia in patients undergoing colorectal surgery-a prospective study. Tech Coloproctol. 2025 Apr 5;29(1):92. doi: 10.1007/s10151-025-03131-5.

MeSH Terms

Conditions

Intraoperative Awareness

Condition Hierarchy (Ancestors)

Intraoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Open label multicenter trial with historic controls
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Gastrointestinal Surgeon

Study Record Dates

First Submitted

January 20, 2022

First Posted

February 22, 2022

Study Start

September 5, 2021

Primary Completion

September 1, 2023

Study Completion

December 1, 2023

Last Updated

February 22, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

The datasets generated during and/or analysed during the current study are/will be available upon request from dr. F. Daams

Time Frame
Upon request
Access Criteria
Upon request

Locations